PHCRF.US Healius Limited

Healthcare Diagnostics & Research USA Stocks
0.8400 USD
Close of Nov 16, 2026
0.8400 0.8400
Market cap
USD 610M
P/E
28.0x
P/B
0.99x
ROE
-242.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Jun 2026.

Is PHCRF.US undervalued?

Graham number
Price0.8400
Graham value0.7556
Premium11.2%

PHCRF.US trades 11.2% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Healius Limited fundamental analysis

No fundamental analysis for Healius Limited yet.

Healius Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Healius Limited

Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab Dermatopathology, and Agilex Biolabs brands. It operates medical laboratories and patient collection centers. The company was formerly known as Primary Health Care L…

Full company profile